630 related articles for article (PubMed ID: 12700423)
1. Type 1 diabetic mice are protected from acetaminophen hepatotoxicity.
Shankar K; Vaidya VS; Apte UM; Manautou JE; Ronis MJ; Bucci TJ; Mehendale HM
Toxicol Sci; 2003 Jun; 73(2):220-34. PubMed ID: 12700423
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of type 2 diabetes on acetaminophen-induced hepatotoxicity in male Swiss-Webster mice.
Sawant SP; Dnyanmote AV; Mitra MS; Chilakapati J; Warbritton A; Latendresse JR; Mehendale HM
J Pharmacol Exp Ther; 2006 Feb; 316(2):507-19. PubMed ID: 16207833
[TBL] [Abstract][Full Text] [Related]
3. Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality.
Chanda S; Mangipudy RS; Warbritton A; Bucci TJ; Mehendale HM
Hepatology; 1995 Feb; 21(2):477-86. PubMed ID: 7843722
[TBL] [Abstract][Full Text] [Related]
4. Geranylgeranylacetone protects against acetaminophen-induced hepatotoxicity by inducing heat shock protein 70.
Nishida T; Matsura T; Nakada J; Togawa A; Kai M; Sumioka I; Minami Y; Inagaki Y; Ishibe Y; Ito H; Ohta Y; Yamada K
Toxicology; 2006 Feb; 219(1-3):187-96. PubMed ID: 16377054
[TBL] [Abstract][Full Text] [Related]
5. Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats.
Wang T; Fontenot RD; Soni MG; Bucci TJ; Mehendale HM
Toxicol Appl Pharmacol; 2000 Jul; 166(2):92-100. PubMed ID: 10896850
[TBL] [Abstract][Full Text] [Related]
6. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.
Zaher H; Buters JT; Ward JM; Bruno MK; Lucas AM; Stern ST; Cohen SD; Gonzalez FJ
Toxicol Appl Pharmacol; 1998 Sep; 152(1):193-9. PubMed ID: 9772215
[TBL] [Abstract][Full Text] [Related]
7. Activation of PPAR-alpha in streptozotocin-induced diabetes is essential for resistance against acetaminophen toxicity.
Shankar K; Vaidya VS; Corton JC; Bucci TJ; Liu J; Waalkes MP; Mehendale HM
FASEB J; 2003 Sep; 17(12):1748-50. PubMed ID: 12958197
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of salidroside against acetaminophen-induced toxicity in mice.
Wu YL; Piao DM; Han XH; Nan JX
Biol Pharm Bull; 2008 Aug; 31(8):1523-9. PubMed ID: 18670083
[TBL] [Abstract][Full Text] [Related]
9. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury.
Shayiq RM; Roberts DW; Rothstein K; Snawder JE; Benson W; Ma X; Black M
Hepatology; 1999 Feb; 29(2):451-63. PubMed ID: 9918922
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of garlic and related organosulfur compounds on acetaminophen-induced hepatotoxicity in mice.
Wang EJ; Li Y; Lin M; Chen L; Stein AP; Reuhl KR; Yang CS
Toxicol Appl Pharmacol; 1996 Jan; 136(1):146-54. PubMed ID: 8560468
[TBL] [Abstract][Full Text] [Related]
11. Protection afforded by pre- or post-treatment with 4-phenylbutyrate against liver injury induced by acetaminophen overdose in mice.
Shimizu D; Ishitsuka Y; Miyata K; Tomishima Y; Kondo Y; Irikura M; Iwawaki T; Oike Y; Irie T
Pharmacol Res; 2014 Sep; 87():26-41. PubMed ID: 24951965
[TBL] [Abstract][Full Text] [Related]
12. The PPAR activator docosahexaenoic acid prevents acetaminophen hepatotoxicity in male CD-1 mice.
Nguyen KA; Carbone JM; Silva VM; Chen C; Hennig GE; Whiteley HE; Manautou JE
J Toxicol Environ Health A; 1999 Oct; 58(3):171-86. PubMed ID: 10522648
[TBL] [Abstract][Full Text] [Related]
13. Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity.
Sawant SP; Dnyanmote AV; Warbritton A; Latendresse JR; Mehendale HM
Toxicol Appl Pharmacol; 2006 Mar; 211(3):221-32. PubMed ID: 16153671
[TBL] [Abstract][Full Text] [Related]
14. Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes.
Aleksunes LM; Campion SN; Goedken MJ; Manautou JE
Toxicol Sci; 2008 Aug; 104(2):261-73. PubMed ID: 18468992
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic steatohepatitic (NASH) mice are protected from higher hepatotoxicity of acetaminophen upon induction of PPARalpha with clofibrate.
Donthamsetty S; Bhave VS; Mitra MS; Latendresse JR; Mehendale HM
Toxicol Appl Pharmacol; 2008 Aug; 230(3):327-37. PubMed ID: 18501395
[TBL] [Abstract][Full Text] [Related]
16. Streptozotocin-induced diabetic mice are resistant to lethal effects of thioacetamide hepatotoxicity.
Shankar K; Vaidya VS; Wang T; Bucci TJ; Mehendale HM
Toxicol Appl Pharmacol; 2003 Apr; 188(2):122-34. PubMed ID: 12691730
[TBL] [Abstract][Full Text] [Related]
17. CHOP is a critical regulator of acetaminophen-induced hepatotoxicity.
Uzi D; Barda L; Scaiewicz V; Mills M; Mueller T; Gonzalez-Rodriguez A; Valverde AM; Iwawaki T; Nahmias Y; Xavier R; Chung RT; Tirosh B; Shibolet O
J Hepatol; 2013 Sep; 59(3):495-503. PubMed ID: 23665281
[TBL] [Abstract][Full Text] [Related]
18. Hepatoprotective role of endogenous interleukin-13 in a murine model of acetaminophen-induced liver disease.
Yee SB; Bourdi M; Masson MJ; Pohl LR
Chem Res Toxicol; 2007 May; 20(5):734-44. PubMed ID: 17439248
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defence response pathway in CD-1 mice.
Randle LE; Goldring CE; Benson CA; Metcalfe PN; Kitteringham NR; Park BK; Williams DP
Toxicology; 2008 Jan; 243(3):249-60. PubMed ID: 18078705
[TBL] [Abstract][Full Text] [Related]
20. Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality.
Wang T; Shankar K; Bucci TJ; Warbritton A; Mehendale HM
Toxicol Appl Pharmacol; 2001 May; 173(1):27-37. PubMed ID: 11350212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
